< Back to search
Filter
1

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

for
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Male

Age: 18+

Code: NCT06067269

Phase2, Recruiting

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Male

Age: 18+

Code: NCT06193486

Phase1, Recruiting

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

for
Prostate Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Male

Age: 40 - 70+

Code: NCT03769766

Phase3, Recruiting

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

for
Prostate Cancer
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Male

Age: 40 - 70+

Code: NCT03620786

Recruiting

MR/TRUS Fusion Guided Prostate Biopsy

for
Prostate Disease, Elevated Prostate Specific Antigen,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male

Age: 18+

Code: NCT04026763

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

for
CNS Cancer, Head and Neck Cancer, GI Cancer, Gynecologic Cancer,
Location: New York NY
Sponsor: The New York Proton Center

Sex: All

Age: 18+

Code: NCT05313191

Recruiting

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

for
Prostatic Cancer
Location: Omaha NE
Sponsor: University of Nebraska

Sex: Male

Age: 19+

Code: NCT05754580

Recruiting

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Lake Success NY, New York NY, Miami FL, Pittsburgh PA,
Sponsor: Syncromune, Inc.

Sex: Male

Age: 18+

Code: NCT06533644

Phase2, Recruiting

Outcomes of Focal Ablation for Prostate Cancer

for
Prostate Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Male

Age: 18 - 70+

Code: NCT05478694

Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Boston MA, Miami FL, Denver CO, Nashville TN,
Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All

Age: 18+

Code: NCT06239194

Phase1, Phase2, Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

for
Solid Tumor, Renal Cell Cancer Metastatic,
Location: Philadelphia PA, Dallas TX
Sponsor: Eutilex

Sex: All

Age: 18+

Code: NCT04903873

Phase1, Phase2, Recruiting

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase1, Phase2, Recruiting

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

for
Prostate Cancer
Location: Dallas TX
Sponsor: yair lotan

Sex: Male

Age: 30 - 70+

Code: NCT02064673

Phase3, Recruiting

Low-Count Quantitative SPECT for Men Treated With Radium-223

for
Prostate Cancer, Cancer of the Prostate
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Male

Age: 18+

Code: NCT07221825

Recruiting

A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT07677254

Recruiting

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

for
Prostatic Neoplasms, Castration-Resistant
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT07677267

Recruiting

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

for
Metastatic Castration-Resistant Prostatic Cancer
Location: Toronto
Sponsor: T.O.A.D. Oncology SA

Sex: Male

Age: 18+

Code: NCT07258407

Phase1, Phase2, Recruiting

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Male

Age: 18+

Code: NCT07476001

Phase2, Recruiting

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

for
Localized Prostate Adenocarcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Male

Age: 18+

Code: NCT07276438

Recruiting

Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

for
Prostate Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Male

Age: 18+

Code: NCT07313241

Phase2, Recruiting